Outcomes of 3 patients with adenosine deaminase deficiency on long-term enzyme replacement therapy.
作者信息
Gans Melissa D, Bernstein Larry, Shliozberg Jenny, Gavrilova Tatyana, Rubinstein Arye
机构信息
Division of Pediatric Pulmonology, Allergy, Immunology, and Sleep Medicine, Westchester Medical Center/Boston Children's Health Physicians, New York Medical College, Hawthorne, New York.
Division of Allergy and Immunology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.
出版信息
Ann Allergy Asthma Immunol. 2021 May;126(5):593-595. doi: 10.1016/j.anai.2020.12.008. Epub 2021 Jan 30.
PMID:33359138
Abstract
摘要
相似文献
1
Outcomes of 3 patients with adenosine deaminase deficiency on long-term enzyme replacement therapy.3例腺苷脱氨酶缺乏症患者长期酶替代治疗的结果。
Ann Allergy Asthma Immunol. 2021 May;126(5):593-595. doi: 10.1016/j.anai.2020.12.008. Epub 2021 Jan 30.
2
Effects of enzyme replacement therapy on immune function in ADA deficiency patient.酶替代疗法对腺苷脱氨酶缺乏症患者免疫功能的影响。
Clin Immunol. 2015 Dec;161(2):391-3. doi: 10.1016/j.clim.2015.06.011. Epub 2015 Jun 27.
3
Management of ADA-Deficient SCID Patient on Adagen During Pregnancy.孕期使用阿糖苷酶α治疗腺苷脱氨酶缺乏性重症联合免疫缺陷病患者的管理
J Clin Immunol. 2019 Nov;39(8):846-848. doi: 10.1007/s10875-019-00692-7. Epub 2019 Oct 16.
4
Successful Long-Term Enzyme Replacement Therapy in a Patient with Delayed-Onset ADA Deficiency.迟发性腺苷脱氨酶缺乏症患者的长期酶替代疗法成功案例
J Clin Immunol. 2024 Sep 12;45(1):8. doi: 10.1007/s10875-024-01794-7.
5
Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy.腺苷脱氨酶缺乏症患者接受酶替代治疗 27 年期间的发病率。
Clin Immunol. 2020 Feb;211:108321. doi: 10.1016/j.clim.2019.108321. Epub 2019 Dec 5.
6
A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient.对一名腺苷脱氨酶缺乏患者进行的24年酶替代疗法
Pediatrics. 2016 Jan;137(1). doi: 10.1542/peds.2015-2169. Epub 2015 Dec 18.
7
Burkitt's lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminase.一名腺苷脱氨酶缺乏-重症联合免疫缺陷患者患伯基特淋巴瘤，接受聚乙二醇化腺苷脱氨酶治疗。
J Pediatr. 2007 Jul;151(1):93-5. doi: 10.1016/j.jpeds.2007.03.059.
8
Severe combined immunodeficiency due to adenosine deaminase deficiency.腺苷脱氨酶缺乏所致重症联合免疫缺陷
J Pak Med Assoc. 2012 Mar;62(3):297-9.
9
Successful treatment with cyclosporine and anti-tumour necrosis factor agent for deficiency of adenosine deaminase-2.环孢素和抗肿瘤坏死因子药物成功治疗腺苷脱氨酶2缺乏症。
Scand J Rheumatol. 2021 May;50(3):243-245. doi: 10.1080/03009742.2020.1772868. Epub 2020 Jul 28.
10
Treatment of Two Boys Suffering From Deficiency of Adenosine Deaminase Type 2 (DADA2) With TNF-Inhibitor Etanercept.用肿瘤坏死因子抑制剂依那西普治疗两名患有2型腺苷脱氨酶缺乏症（DADA2）的男孩。
J Clin Rheumatol. 2021 Dec 1;27(8S):S509-S512. doi: 10.1097/RHU.0000000000001145.
引用本文的文献
1
Successful Long-Term Enzyme Replacement Therapy in a Patient with Delayed-Onset ADA Deficiency.迟发性腺苷脱氨酶缺乏症患者的长期酶替代疗法成功案例
J Clin Immunol. 2024 Sep 12;45(1):8. doi: 10.1007/s10875-024-01794-7.
2
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC.ADA 缺陷型严重联合免疫缺陷症治疗后的结果：PIDTC 的报告。
Blood. 2022 Aug 18;140(7):685-705. doi: 10.1182/blood.2022016196.
Zotero 插件